Review Article
Prostate-Specific Membrane Antigen as Target for Neuroimaging of Central Nervous System Tumors
Figure 6
Response to 225Ac-PSMA-617 therapy in a representative prostate cancer brain metastasis. (a) Pretreatment 68Ga-PSMA PET/CT. (b) Restaging PSMA PET/CT scan after one cycle of 225Ac-PSMA. Reproduced with permission from Sathekge et al. [64].
(a) |
(b) |